Investment
Features
FeesSafety
Academy
More
Pluang+

Allegiant wins Best Low-Cost Airline in North America for third year in a row, boosting its market position.

Market News
18 Sep 2026
PRNewsWire
View Source
Bullish
Allegiant wins Best Low-Cost Airline in North America for third year in a row, boosting its market position.

Allegiant Travel Company was named the Best Low-Cost Airline in North America by Skytrax for the third consecutive year in 2026, recognized for its outstanding customer service. This award reflects Allegiant's consistent focus on providing a seamless, comfortable travel experience, supported by a large global passenger satisfaction survey. The airline continues to expand through integration with Sun Country Airlines, aiming for a unified customer experience across nearly 175 cities with a fleet of about 200 aircraft. This recognition reinforces Allegiant's position as a leading value-focused airline in the U.S., known for affordable, reliable service and nonstop flights to underserved communities.

Allegiant's recognition as the Best Low-Cost Airline in North America provides context for consumer-focused sectors. For readers following Consumer Cyclical stocks, here is Pluang's market snapshot as of Sep 18, 2026 19:01 WIB: out of 107 priced US stocks, 65 rose and 36 fell. Notable movers include Alibaba Group (BABA) at USD 110.99 with a 1-day change of +2.27% and typical hold time on Pluang of 110 days, NIO Inc. (NIO) at USD 3.69 with a 1-day change of +2.07% and typical hold time of 81 days, and Plby Group Inc. (PLBY) at USD 1.09 with a 1-day change of +1.87% and typical hold time of 22 days.

More News

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...

Analyst Insights
Bullish
46 minutes ago
Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
1 hour ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
2 hours ago
Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...

Company Fundamentals
Bullish
3 hours ago
Barclays cuts Lennar price target to $70 amid weak Q3 earnings and housing market challenges

Barclays cuts Lennar price target to $70 amid weak Q3 earnings and housing market challenges

Barclays lowered its price target for Lennar Corporation to $70 from a higher level, citing a 52% drop in Q3 net earnings to $284 million and an 8.6% revenue decline to $8.05 billion. The homebuilder faces headwinds from rising mortgage rates and wea...

Analyst Insights
Bearish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App